Journal of Leukocyte Biology eBioscience full spectrum cell analysis
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Smyth, M. J.
Right arrow Articles by Trapani, J. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Smyth, M. J.
Right arrow Articles by Trapani, J. A.
(Journal of Leukocyte Biology. 2001;70:18-29.)
© 2001 by Society for Leukocyte Biology

Unlocking the secrets of cytotoxic granule proteins

Mark J. Smyth*, Janice M. Kelly*, Vivien R. Sutton*, Joanne E. Davis*, Kylie A. Browne*, Thomas J. Sayers{dagger} and Joseph A. Trapani*

* Cancer Immunology Division, Trescowthick Laboratories, Peter MacCallum Cancer Institute, Melbourne, Australia; and
{dagger} Laboratory of Experimental Immunology, National Cancer Institute, FDR-DC, NIH, Frederick, Maryland

Correspondence: Mark J. Smyth, Cancer Immunology Division, Trescowthick Laboratories, Peter MacCallum Cancer Institute, Locked Bag 1, A’Beckett St, 8006, Melbourne, Australia. E-mail: m.smyth{at}pmci.unimelb.edu.au

Cytotoxic lymphocytes largely comprise CD8+ cytotoxic T cells and natural killer cells and form the major defense of higher organisms against virus-infected and transformed cells. A key function of cytotoxic lymphocytes is to detect and eliminate potentially harmful cells by inducing them to undergo apoptosis. This is achieved through two principal pathways, both of which require direct but transient contact between the killer cell and its target. The first, involving ligation of TNF receptor-like molecules such as Fas/CD95 by their cognate ligands, results in mobilization of conventional, programmed cell-death pathways centered on activation of pro-apoptotic caspases. This review concentrates on the second pathway, in which the toxic contents of secretory vesicles of the cytotoxic lymphocyte are secreted toward the target cell, and some toxins penetrate into the target cell cytoplasm and nucleus. In addition to invoking a powerful stimulus to caspase activation, this "granule-exocytosis mechanism" provides a variety of additional strategies for overcoming inhibitors of the caspase cascade that may be elaborated by viruses. The key molecular players in this process are the pore-forming protein perforin and a family of granule-bound serine proteases or granzymes. The molecular functions of perforin and granzymes are under intense investigation in many laboratories including our own, and recent advances will be discussed. In addition, this review discusses the evidence pointing to the importance of perforin and granzyme function in pathophysiological situations as diverse as infection with intracellular pathogens, graft versus host disease, susceptibility to transplantable and spontaneous malignancies, lymphoid homeostasis, and the tendency to auto-immune diseases.

Key Words: apoptosis • lymphocyte • granzyme • perforin • granulysin




This article has been cited by other articles:


Home page
J. Immunol.Home page
M. R. Jenkins, J. Mintern, N. L. La Gruta, K. Kedzierska, P. C. Doherty, and S. J. Turner
Cell Cycle-Related Acquisition of Cytotoxic Mediators Defines the Progressive Differentiation to Effector Status for Virus-Specific CD8+ T Cells
J. Immunol., September 15, 2008; 181(6): 3818 - 3822.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. Grujic, J. P. Christensen, M. R. Sorensen, M. Abrink, G. Pejler, and A. R. Thomsen
Delayed Contraction of the CD8+ T Cell Response toward Lymphocytic Choriomeningitis Virus Infection in Mice Lacking Serglycin
J. Immunol., July 15, 2008; 181(2): 1043 - 1051.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
W. L. Redmond, M. J. Gough, B. Charbonneau, T. L. Ratliff, and A. D. Weinberg
Defects in the Acquisition of CD8 T Cell Effector Function after Priming with Tumor or Soluble Antigen Can Be Overcome by the Addition of an OX40 Agonist
J. Immunol., December 1, 2007; 179(11): 7244 - 7253.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. M. Moretto, L. M. Weiss, C. L. Combe, and I. A. Khan
IFN-{gamma}-Producing Dendritic Cells Are Important for Priming of Gut Intraepithelial Lymphocyte Response Against Intracellular Parasitic Infection
J. Immunol., August 15, 2007; 179(4): 2485 - 2492.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. R. Jenkins, K. Kedzierska, P. C. Doherty, and S. J. Turner
Heterogeneity of Effector Phenotype for Acute Phase and Memory Influenza A Virus-Specific CTL
J. Immunol., July 1, 2007; 179(1): 64 - 70.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
B. Heemskerk, T. van Vreeswijk, L. A. Veltrop-Duits, C. C. Sombroek, K. Franken, R. M. Verhoosel, P. S. Hiemstra, D. van Leeuwen, M. E. Ressing, R. E. M. Toes, et al.
Adenovirus-Specific CD4+ T Cell Clones Recognizing Endogenous Antigen Inhibit Viral Replication In Vitro through Cognate Interaction
J. Immunol., December 15, 2006; 177(12): 8851 - 8859.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
J. J. Zaunders, W. B. Dyer, M. L. Munier, S. Ip, J. Liu, E. Amyes, W. Rawlinson, R. De Rose, S. J. Kent, J. S. Sullivan, et al.
CD127+CCR5+CD38+++ CD4+ Th1 Effector Cells Are an Early Component of the Primary Immune Response to Vaccinia Virus and Precede Development of Interleukin-2+ Memory CD4+ T Cells.
J. Virol., October 1, 2006; 80(20): 10151 - 10161.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
A. Gelbard, C. T. Garnett, S. I. Abrams, V. Patel, J. S. Gutkind, C. Palena, K.-Y. Tsang, J. Schlom, and J. W. Hodge
Combination Chemotherapy and Radiation of Human Squamous Cell Carcinoma of the Head and Neck Augments CTL-Mediated Lysis.
Clin. Cancer Res., March 15, 2006; 12(6): 1897 - 1905.
[Abstract] [Full Text] [PDF]


Home page
ASH Education BookHome page
E. S. Jaffe
Pathobiology of Peripheral T-cell Lymphomas
Hematology, January 1, 2006; 2006(1): 317 - 322.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
L. I. Pao, N. Sumaria, J. M. Kelly, S. v. Dommelen, E. Cretney, M. E. Wallace, D. A. Anthony, A. P. Uldrich, D. I. Godfrey, J. M. Papadimitriou, et al.
Functional Analysis of Granzyme M and Its Role in Immunity to Infection
J. Immunol., September 1, 2005; 175(5): 3235 - 3243.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
J. Oliaro, S. Dudal, J. Liautard, J.-B. Andrault, J.-P. Liautard, and V. Lafont
V{gamma}9V{delta}2 T cells use a combination of mechanisms to limit the spread of the pathogenic bacteria Brucella
J. Leukoc. Biol., May 1, 2005; 77(5): 652 - 660.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. Walch, E. Eppler, C. Dumrese, H. Barman, P. Groscurth, and U. Ziegler
Uptake of Granulysin via Lipid Rafts Leads to Lysis of Intracellular Listeria innocua
J. Immunol., April 1, 2005; 174(7): 4220 - 4227.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. S. Bharhani, J. S. Grewal, M. J. Pilgrim, C. Enocksen, R. Peppler, L. London, and S. D. London
Reovirus Serotype 1/Strain Lang-Stimulated Activation of Antigen-Specific T Lymphocytes in Peyer's Patches and Distal Gut-Mucosal Sites: Activation Status and Cytotoxic Mechanisms
J. Immunol., March 15, 2005; 174(6): 3580 - 3589.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. A. Rutigliano and B. S. Graham
Prolonged Production of TNF-{alpha} Exacerbates Illness during Respiratory Syncytial Virus Infection
J. Immunol., September 1, 2004; 173(5): 3408 - 3417.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
D. Hongo, J. S. Bryson, A. M. Kaplan, and D. A. Cohen
Endogenous Nitric Oxide Protects against T Cell-Dependent Lethality during Graft-versus-Host Disease and Idiopathic Pneumonia Syndrome
J. Immunol., August 1, 2004; 173(3): 1744 - 1756.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
B. L. Shacklett, C. A. Cox, M. F. Quigley, C. Kreis, N. H. Stollman, M. A. Jacobson, J. Andersson, J. K. Sandberg, and D. F. Nixon
Abundant Expression of Granzyme A, but Not Perforin, in Granules of CD8+ T Cells in GALT: Implications for Immune Control of HIV-1 Infection
J. Immunol., July 1, 2004; 173(1): 641 - 648.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
J. J. Zaunders, W. B. Dyer, B. Wang, M. L. Munier, M. Miranda-Saksena, R. Newton, J. Moore, C. R. Mackay, D. A. Cooper, N. K. Saksena, et al.
Identification of circulating antigen-specific CD4+ T lymphocytes with a CCR5+, cytotoxic phenotype in an HIV-1 long-term nonprogressor and in CMV infection
Blood, March 15, 2004; 103(6): 2238 - 2247.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
S. Nikiforow, K. Bottomly, G. Miller, and C. Munz
Cytolytic CD4+-T-Cell Clones Reactive to EBNA1 Inhibit Epstein-Barr Virus-Induced B-Cell Proliferation
J. Virol., November 15, 2003; 77(22): 12088 - 12104.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
F. Andrade, L. A. Casciola-Rosen, and A. Rosen
A Novel Domain in Adenovirus L4-100K Is Required for Stable Binding and Efficient Inhibition of Human Granzyme B: Possible Interaction with a Species-Specific Exosite
Mol. Cell. Biol., September 1, 2003; 23(17): 6315 - 6326.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
I. Barao, D. Hudig, and J. L. Ascensao
IL-15-Mediated Induction of LFA-1 Is a Late Step Required for Cytotoxic Differentiation of Human NK Cells from CD34+Lin- Bone Marrow Cells
J. Immunol., July 15, 2003; 171(2): 683 - 690.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
L. Krenacs, M. J. Smyth, E. Bagdi, T. Krenacs, L. Kopper, T. Rudiger, A. Zettl, H. K. Muller-Hermelink, E. S. Jaffe, and M. Raffeld
The serine protease granzyme M is preferentially expressed in NK-cell, gamma delta T-cell, and intestinal T-cell lymphomas: evidence of origin from lymphocytes involved in innate immunity
Blood, May 1, 2003; 101(9): 3590 - 3593.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
B. J. Johnson, E. O. Costelloe, D. R. Fitzpatrick, J. B. A. G. Haanen, T. N. M. Schumacher, L. E. Brown, and A. Kelso
Single-cell perforin and granzyme expression reveals the anatomical localization of effector CD8+ T cells in influenza virus-infected mice
PNAS, March 4, 2003; 100(5): 2657 - 2662.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
E. Wieckowski, G.-Q. Wang, B. R. Gastman, L. A. Goldstein, and H. Rabinowich
Granzyme B-mediated Degradation of T-Cell Receptor {zeta} Chain
Cancer Res., September 1, 2002; 62(17): 4884 - 4889.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
N. Bidere, M. Briet, A. Durrbach, C. Dumont, J. Feldmann, B. Charpentier, G. de Saint-Basile, and A. Senik
Selective Inhibition of Dipeptidyl Peptidase I, Not Caspases, Prevents the Partial Processing of Procaspase-3 in CD3-activated Human CD8+ T Lymphocytes
J. Biol. Chem., August 23, 2002; 277(35): 32339 - 32347.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
A. Kelso, E. O. Costelloe, B. J. Johnson, P. Groves, K. Buttigieg, and D. R. Fitzpatrick
The genes for perforin, granzymes A-C and IFN-{gamma} are differentially expressed in single CD8+ T cells during primary activation
Int. Immunol., June 1, 2002; 14(6): 605 - 613.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
Z. Fan, P. J. Beresford, D. Zhang, and J. Lieberman
HMG2 Interacts with the Nucleosome Assembly Protein SET and Is a Target of the Cytotoxic T-Lymphocyte Protease Granzyme A
Mol. Cell. Biol., April 15, 2002; 22(8): 2810 - 2820.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2001 by the Society for Leukocyte Biology.